These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
79 related articles for article (PubMed ID: 7172006)
1. Non-competitive interaction between normorphine and calcium on the release of noradrenaline. Illes P; Meier C; Starke K Brain Res; 1982 Nov; 251(1):192-5. PubMed ID: 7172006 [TBL] [Abstract][Full Text] [Related]
2. The calcium-magnesium interaction in the process of release of noradrenaline by nicotine. Jayasundar S; Vohra MM Can J Physiol Pharmacol; 1977 Dec; 55(6):1383-6. PubMed ID: 597785 [TBL] [Abstract][Full Text] [Related]
3. The effects of morphine on the release of noradrenaline from the mouse vas deferens. Henderson G; Hughes J Br J Pharmacol; 1976 Aug; 57(4):551-7. PubMed ID: 963343 [TBL] [Abstract][Full Text] [Related]
4. Interactions among the effects of normorphine, calcium and magnesium on transmitter release in the mouse vas deferens. Milner JD; North RA; Vitek LV Br J Pharmacol; 1982 May; 76(1):45-9. PubMed ID: 6123358 [TBL] [Abstract][Full Text] [Related]
5. Electrotonic depolarization of nerve terminals causes a normorphine-resistant release of transmitter. Illes P; Meier C; Starke K Life Sci; 1982 Nov 15-22; 31(20-21):2279-82. PubMed ID: 7162343 [TBL] [Abstract][Full Text] [Related]
6. Tetrodotoxin-resistant release of 3H-noradrenaline from the mouse vas deferens by high intensity electrical stimulation. Illes P; Meier C; Starke K Neuroscience; 1984 Mar; 11(3):715-21. PubMed ID: 6717806 [TBL] [Abstract][Full Text] [Related]
7. Effect of morphine on adrenergic transmission in the mouse vas deferens. Assessment of agonist and antogonist potencies of narcotic analgesics. Hughes J; Kosterlitz HW; Leslie FM Br J Pharmacol; 1975 Mar; 53(3):371-81. PubMed ID: 236796 [TBL] [Abstract][Full Text] [Related]
8. Calcium reverses the inhibitory action of morphine on neuroeffector transmission in the mouse vas deferens. Illes P; Zieglgänsberger W; Herz A Brain Res; 1980 Jun; 191(2):511-22. PubMed ID: 6247017 [TBL] [Abstract][Full Text] [Related]
9. Calcium ions, morphine tolerance and noradrenergic transmission in the mouse vas deferens. Marshall I; Phillips DG; Nasmyth PA Eur J Pharmacol; 1981 Nov; 75(4):205-13. PubMed ID: 6274667 [TBL] [Abstract][Full Text] [Related]
10. Effect of blockade of noradrenaline re-uptake on evoked tritium overflow from mouse vasa deferentia and rat cortex slices. el-Mas M; Hughes IE Br J Pharmacol; 1990 Nov; 101(3):762-8. PubMed ID: 2076491 [TBL] [Abstract][Full Text] [Related]
11. Release of 3H-noradrenaline from the rat vas deferens under various in vitro conditions. Ross SB; Kelder D Acta Physiol Scand; 1979 Mar; 105(3):338-49. PubMed ID: 443064 [TBL] [Abstract][Full Text] [Related]
12. Depression by morphine of excitatory junction potentials in the vas deferens of the mouse. Henderson G; North RA Br J Pharmacol; 1976 Jul; 57(3):341-6. PubMed ID: 974315 [TBL] [Abstract][Full Text] [Related]
13. An electrophysiological analysis of the effect of Ca ions on neuromuscular transmission in the mouse vas deferens. Bennett MR; Florin T Br J Pharmacol; 1975 Sep; 55(1):97-104. PubMed ID: 171018 [TBL] [Abstract][Full Text] [Related]
14. Interaction between prostaglandins and calcium ions on noradrenaline release from the stimulated guinea pig vas deferens. Hedqvist P Acta Physiol Scand; 1974 Jan; 90(1):153-7. PubMed ID: 4814530 [No Abstract] [Full Text] [Related]
15. Site(s) and ionic basis of alpha-autoinhibition and facilitation of "3H'noradrenaline secretion in guinea-pig vas deferens. Alberts P; Bartfai T; Stjärne L J Physiol; 1981 Mar; 312():297-334. PubMed ID: 6267264 [TBL] [Abstract][Full Text] [Related]
16. Clonidine and morphine increase [3H]-noradrenaline overflow in mouse vas deferens. Forsyth KM; Pollock D Br J Pharmacol; 1988 Jan; 93(1):35-42. PubMed ID: 3349232 [TBL] [Abstract][Full Text] [Related]
17. Bradykinin modulates the release of noradrenaline from vas deferens nerve terminals. Llona I; Galleguillos X; Belmar J; Huidobro-Toro JP Life Sci; 1991; 48(26):2585-92. PubMed ID: 2046481 [TBL] [Abstract][Full Text] [Related]
18. The effect of chronic morphine treatment of excitatory junction potentials in the mouse vas deferens. North RA; Vitek LV Br J Pharmacol; 1980 Mar; 68(3):399-405. PubMed ID: 7052335 [TBL] [Abstract][Full Text] [Related]
19. Availability of calcium for noradrenergic contraction of the mouse isolated vas deferens is not altered during tolerance to and dependence on morphine. Rae GA Braz J Med Biol Res; 1990; 23(3-4):307-15. PubMed ID: 2094543 [TBL] [Abstract][Full Text] [Related]
20. Proceedings: Is morphine inhibition to the twitch response of the mouse vas deferens mediated via noradrenaline? Jenkins DA; Marshall I; Nasmyth PA Br J Pharmacol; 1975 Oct; 55(2):267P-268P. PubMed ID: 1201407 [No Abstract] [Full Text] [Related] [Next] [New Search]